Return to search

Situation analysis study on nanomedicines regulation and assessment practices in Zazibona active countries

>Magister Scientiae - MSc / Nanomedicines are loosely defined as medicines that seek to apply nanotechnology. Currently,
nanomedicines are available for clinical use, including treatments for cancer, high cholesterol,
hepatitis, COVID-19 vaccination, among other uses (Patra et al., 2018; Gao et al., 2021). Most
of the nanomedicines meet the definition of medicines according to various national
legislations. Consequently, these products are regulated as medicines. Nanomedicines present
major differences in biological details and increased complexity of clinical use. They integrate
different technology subsets from therapeutics to imaging and integrated non-invasive
diagnosis (Gaspar, 2007). These complexities require extra regulatory effort.

Identiferoai:union.ndltd.org:netd.ac.za/oai:union.ndltd.org:uwc/oai:etd.uwc.ac.za:11394/8971
Date January 2021
CreatorsMudyiwenyama, Linda Gracious
ContributorsDube, Admire
PublisherUniversity of Western Cape
Source SetsSouth African National ETD Portal
LanguageEnglish
Detected LanguageEnglish
Formatapplication/pdf
RightsUniversity of Western Cape

Page generated in 0.0016 seconds